CKDXFOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as CYVNY
Opthea Ltd
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Sep 15, 2025
$0.01+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.4300 (−97.73%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Opthea Ltd saw revenue fall 80.0% to $25.00K over fiscal 2025. Free cash flow was -$158.66M.
Revenue
$25.00K
-80.0% vs. a year earlier
Operating income
-$155.76M
FY2025
Free cash flow
-$158.66M
FY2025
EPS, diluted
-$0.13
FY2025
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $25.00K
- Net income
- -$162.79M
- EPS, diluted
- -$0.13
- Free cash flow
- -$158.66M
Eight years at a glance
Fiscal years 2018 to 2025, USD
Revenue
$25.00K-80.0% YoY
Operating income
-$155.76M
Net income
-$162.79M
EPS, diluted
-$0.13
Free cash flow
-$158.66M
Reported period